Literature DB >> 11966386

The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Diane Solomon1, Diane Davey, Robert Kurman, Ann Moriarty, Dennis O'Connor, Marianne Prey, Stephen Raab, Mark Sherman, David Wilbur, Thomas Wright, Nancy Young.   

Abstract

OBJECTIVES: The Bethesda 2001 Workshop was convened to evaluate and update the 1991 Bethesda System terminology for reporting the results of cervical cytology. A primary objective was to develop a new approach to broaden participation in the consensus process. PARTICIPANTS: Forum groups composed of 6 to 10 individuals were responsible for developing recommendations for discussion at the workshop. Each forum group included at least 1 cytopathologist, cytotechnologist, clinician, and international representative to ensure a broad range of views and interests. More than 400 cytopathologists, cytotechnologists, histopathologists, family practitioners, gynecologists, public health physicians, epidemiologists, patient advocates, and attorneys participated in the workshop, which was convened by the National Cancer Institute and cosponsored by 44 professional societies. More than 20 countries were represented. EVIDENCE: Literature review, expert opinion, and input from an Internet bulletin board were all considered in developing recommendations. The strength of evidence of the scientific data was considered of paramount importance. CONSENSUS PROCESS: Bethesda 2001 was a year-long iterative review process. An Internet bulletin board was used for discussion of issues and drafts of recommendations. More than 1000 comments were posted to the bulletin board over the course of 6 months. The Bethesda Workshop, held April 30-May 2, 2001, was open to the public. Postworkshop recommendations were posted on the bulletin board for a last round of critical review prior to finalizing the terminology.
CONCLUSIONS: Bethesda 2001 was developed with broad participation in the consensus process. The 2001 Bethesda System terminology reflects important advances in biological understanding of cervical neoplasia and cervical screening technology.

Entities:  

Mesh:

Year:  2002        PMID: 11966386     DOI: 10.1001/jama.287.16.2114

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  673 in total

1.  Patterns of cellular and HPV 16 methylation as biomarkers for cervical neoplasia.

Authors:  Divya A Patel; Laura S Rozek; Justin A Colacino; Adrienne Van Zomeren-Dohm; Mack T Ruffin; Elizabeth R Unger; Dana C Dolinoy; David C Swan; Juanita Onyekwuluje; Cecilia R DeGraffinreid; Electra D Paskett
Journal:  J Virol Methods       Date:  2012-06-01       Impact factor: 2.014

2.  Evaluation of a new DNA test for detection of carcinogenic human papillomavirus.

Authors:  Philip E Castle; Erin C Gutierrez; Sharon V Leitch; Courtney E Maus; Ray A McMillian; William A Nussbaumer; Laurence M Vaughan; Cosette M Wheeler; Patti E Gravitt; Mark Schiffman
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

3.  Policy implications of adjusting randomized trial data for economic evaluations: a demonstration from the ASCUS-LSIL Triage Study.

Authors:  Nicole G Campos; Philip E Castle; Mark Schiffman; Jane J Kim
Journal:  Med Decis Making       Date:  2011-12-06       Impact factor: 2.583

4.  Descriptive epidemiology of Pap test results from women with gynecologic symptoms in Georgia.

Authors:  Robert A Bednarczyk; Eka Kldiashvili; Maia Butsashvili; George Kamkamidze; Louise-Anne McNutt
Journal:  Int J Gynaecol Obstet       Date:  2011-01-26       Impact factor: 3.561

5.  Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).

Authors:  Carmen Hidalgo-Tenorio; Jessica Ramírez-Taboada; Concepción Gil-Anguita; Javier Esquivias; Mohamed Omar-Mohamed-Balgahata; Antonio SamPedro; Miguel Lopez-Ruz; Juan Pasquau
Journal:  AIDS Res Ther       Date:  2017-07-18       Impact factor: 2.250

6.  Clinicopathological significance of atypical glandular cells on Pap smear.

Authors:  Sun-Suk Kim; Dong-Soo Suh; Ki-Hyung Kim; Man-Soo Yoon; Kyung-Un Choi
Journal:  Obstet Gynecol Sci       Date:  2013-03-12

7.  A Viable and Simple Self-Sampling Method for Human Papillomavirus Detection among South African Adolescents.

Authors:  David H Adler; Fatima Laher; Erica Lazarus; Katherine Grzesik; Glenda E Gray; Bruce Allan; Anna-Lise Williamson
Journal:  J Immunol Tech Infect Dis       Date:  2013-09-18

8.  Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance.

Authors:  Manola Comar; Michelle R Iannacone; Giorgia Casalicchio; Sandrine McKay-Chopin; Massimo Tommasino; Tarik Gheit
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

9.  Human papillomavirus-related gynecologic neoplasms: screening and prevention.

Authors:  Whitfield B Growdon; Marcela Del Carmen
Journal:  Rev Obstet Gynecol       Date:  2008

10.  National Breast and Cervical Cancer Early Detection Program data validation project.

Authors:  Christie R Eheman; Steven Leadbetter; Vicki B Benard; A Blythe Ryerson; Janet E Royalty; Donald Blackman; Lori A Pollack; Paula Willey Adams; Fran Babcock
Journal:  Cancer       Date:  2014-08-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.